COPD Devices Market: Inhalers Segment to Expand Significantly

Albany NY, United States: Expansion in Emerging Economies of Asia Pacific and Latin America to Offer Growth Opportunities

  • Asia Pacific is a rapidly growing market for COPD devices. Technological advancements and improving health care infrastructure are expected to drive the market in the region.
  • Significant growth in medical tourism in Asia Pacific is anticipated to result in higher number of pulmonary lung function tests. This is likely to drive the demand for COPD devices market in the region.
  • Large number of geriatric population is suffering from respiratory ailments in most countries, such as Japan, China, and India, thus adding to the patient pool. This is increasing the number of respiratory tests being performed.
  • Japan was the largest COPD devices market in Asia Pacific in 2018. The country‚Äôs dominance in terms of technological advancements in COPD devices can be attributed to better health care facilities, presence of advanced biomedical companies, and large base of geriatric population. According to the United Nations Population Division, Japan had around 9 million people aged 80 years and above in 2013.

Request Brochure of Report:

Key Drivers and Restraints of Global COPD Devices Market

  • Increase in prevalence of respiratory diseases, growth in geriatric population demanding respiratory disease monitoring products, and technological advancements boosting the use of respiratory monitoring devices are driving the COPD devices market. However, low adoption of expensive COPD devices is expected to restrain the market growth during the forecast period.
  • Prevalence rate of respiratory diseases, such as asthma, cystic fibrosis, and COPD is increasing significantly across the globe. According to the Centers for Disease Control and Prevention (CDC), North America accounted for the highest number of asthma and COPD cases in the world in 2012.
  • Manufacturers of COPD devices are integrating enhanced patient monitors, innovative parameters, wireless devices, workflows, and integrated information technology solutions. This has enabled clinicians and health care experts to practice and deliver customized services to patients requiring the respiratory disease treatment.
  • Various manufacturing companies provide not only technologically advanced products, but also value-added services, such as portable and user-friendly devices, and access to clinical information

Request for Covid-19 Impact Analysis:

Inhalers Segment to Expand Significantly

  • Based on type, the global COPD devices market can be divided into inhalers and nebulizers. Inhalers segment can be further sub-segmented into drug powder inhalers (DPIs), metered dose inhalers (MDIs), and soft mist inhalers (SMIs). The nebulizers segment is sub-divided into compressor nebulizers, ultrasonic nebulizers, and mesh nebulizers.
  • Inhalers segment is expected to dominate the market during the forecast period. Increase in incidence rate of respiratory disorders and growing geriatric population are driving the segment. This trend is expected to continue during the forecast period.
  • According to the WHO, the global geriatric population is likely to reach 2 billion (22% of the global population) by 2050 as compared to 617 million in 2015

Enquiry Before Buying:

Hospitals Segment Dominated COPD Devices Market

  • Based on end-user, the global COPD devices market can be classified into hospitals, ambulatory surgical centers, clinics, and others
  • Growth of the hospitals segment can be attributable to increased usage of COPD devices due to rise in the number of hospitalized patients

North America to Lead Global COPD Devices Market

  • In terms of region, the global COPD devices market can be split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the market in 2018, owing to the increase in the incidence of asthma and COPD and rising number of awareness programs initiated by governments regarding availability of technologically advanced respiratory diagnostic procedures
  • The U.S. dominates the market in North America due to high awareness, significant health care budget, early availability of advanced technologies, and high penetration of research activities in the country

Key Manufacturers Operating in Global Market

The global COPD devices market was highly fragmented in 2018. Key manufacturers operating in the global market are:

  • GlaxoSmithKline plc.
  • Novartis AG
  • Merck & Co., Inc.
  • Koninklijke Philips N.V.
  • AstraZeneca
  • 3M
  • Sunovion Pharmaceuticals Inc.
  • Smiths Medical
  • Baxter

More Trending Reports by Transparency Market Research:

COPD Drug Delivery Devices Market: The chronic obstructive pulmonary disease (COPD) drug delivery devices have garnered significant popularity in the past few decades, owing to consistent advancements in technology and development of innovative products. Inhaled medication has emerged as one of the most reliable and effective treatments for a broad range of respiratory diseases such as COPD and asthma.

Asthma and COPD Drugs Market: The U.S. and China market for asthma and chronic obstructive pulmonary disease (COPD) drugs is expected to exhibit growth at a steady pace in the next few years. Factors such as a significant rise prevalence of COPD and asthma in these two countries, advancements in diagnostic methods, and rising awareness among patients regarding the available treatment methods are considered key to the overall growth of the market

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.


Rohit Bhisey
Transparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453



Back to news